HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial
暂无分享,去创建一个
D. Xavier | H. Gerstein | J. Basile | M. Konig | A. Kwan | Sohini Raha | Juan M. Maldonado | Manige Konig | Juan M Maldonado